Does ALEMTUZUMAB Cause Hepatic failure? 52 Reports in FDA Database

Q: Does ALEMTUZUMAB cause Hepatic failure?

52 reports of Hepatic failure have been filed with the FDA for ALEMTUZUMAB, representing 0.4% of all ALEMTUZUMAB adverse event reports.

Q: How dangerous is Hepatic failure from ALEMTUZUMAB?

Of 52 reports, 27 (51.9%) resulted in death and 21 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Hepatic failure have been filed in association with ALEMTUZUMAB (Campath). This represents 0.4% of all adverse event reports for ALEMTUZUMAB.

Reports of Hepatic failure with ALEMTUZUMAB

0.4%

of all ALEMTUZUMAB reports

Deaths

Hospitalizations

How Dangerous Is Hepatic failure From ALEMTUZUMAB?

Of the 52 reports, 27 (51.9%) resulted in death, 21 (40.4%) required hospitalization, and 10 (19.2%) were considered life-threatening.

Is Hepatic failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 52 reports have been filed with the FAERS database.

What Other Side Effects Does ALEMTUZUMAB Cause?

Headache (1,808) Fatigue (1,744) Pyrexia (1,441) Off label use (1,259) Rash (1,094) Nausea (1,053) Dyspnoea (855) Lymphocyte count decreased (852) Asthenia (841) Multiple sclerosis relapse (836)

What Other Drugs Cause Hepatic failure?

ACETAMINOPHEN (1,392) RIBAVIRIN (888) CYCLOPHOSPHAMIDE (629) METHOTREXATE (598) BEVACIZUMAB (558) SOFOSBUVIR (525) RITUXIMAB (513) VINCRISTINE (468) DOXORUBICIN (462) PREDNISOLONE (425)

Which ALEMTUZUMAB Alternatives Have Lower Hepatic failure Risk?

ALEMTUZUMAB vs ALENDRONATE ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL ALEMTUZUMAB vs ALENDRONIC ACID ALEMTUZUMAB vs ALEVE ALEMTUZUMAB vs ALEVE CAPLET

ALEMTUZUMAB Full Profile All Hepatic failure Reports All Drugs Causing Hepatic failure ALEMTUZUMAB Demographics